Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cell Factory is a clinical-stage biotechnology company specializing in the development of extracellular vesicle (EV) and exosome-based therapeutics. As a subsidiary of Esperite NV, the company utilizes its proprietary CF-MEV platform to produce standardized, high-purity mesenchymal stem cell-derived vesicles for the treatment of inflammatory and autoimmune disorders. Their lead candidate is currently being evaluated in clinical trials for the treatment of perianal fistulas in patients with Crohn's disease. By focusing on the secretome of stem cells, The Cell Factory aims to deliver the regenerative benefits of cell therapy through a cell-free approach that offers enhanced safety, stability, and scalability. The company operates a GMP-compliant manufacturing facility in Belgium to support its internal pipeline and potential strategic partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cell Factory.